DG Comp orders divestments in Merck/Sigma-Aldrich global life sciences merger
A Bedford, Massachusetts research and development centre used by Merck Millipore, one of the component businesses scrutinised by the European Commission. (Credit: Photo courtesy of Merck KGaA)
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now